TABLE 1.
Brain region | Target | Samples | Average of relative normalized gene expression | SEM | Regulation FC (fold changes) | Compared to Regulation Threshold (FC < −4 down-regulated, FC > 4 up-regulated) |
CC | Adra1d | Control | 1.00 | 0.22 | 7.12 | Up-regulated |
VPA | 7.12 | 9.34 | ||||
Adra2a | Control | 1.00 | 0.12 | 59.61 | Up-regulated | |
VPA | 59.60 | 78.12 | ||||
Chrna5 | Control | 1.00 | 0.15 | 4.07 | Up-regulated | |
VPA | 4.07 | 5.33 | ||||
Chrna7 | Control | 1.00 | 0.15 | 119.63 | Up-regulated | |
VPA | 119.63 | 156.9 | ||||
Chrne | Control | 1.00 | 0.13 | −4.44 | Down-regulated | |
VPA | 0.23 | 0.30 | ||||
Drd2 | Control | 1.00 | 0.19 | −5.33 | Down-regulated | |
VPA | 0.19 | 0.30 | ||||
CE | Adra1a | Control | 1.00 | 0.79 | −5.20 | Down-regulated |
VPA | 0.19 | 0.18 | ||||
Adra1d | Control | 1.00 | 1.09 | −9.52 | Down-regulated | |
VPA | 0.11 | 0.10 | ||||
Adcy7 | Control | 1.00 | 0.48 | −4.21 | Down-regulated | |
VPA | 0.24 | 0.36 | ||||
Chrm1 | Control | 1.00 | 2.39 | −18.70 | Down-regulated | |
VPA | 0.05 | 0.05 | ||||
Chrm4 | Control | 1.00 | 1.94 | −8.29 | Down-regulated | |
VPA | 0.12 | 0.06 | ||||
Chrna5 | Control | 1.00 | 2.69 | −13.32 | Down-regulated | |
VPA | 0.08 | 0.03 | ||||
Chrna7 | Control | 1.00 | 1.02 | −5.15 | Down-regulated | |
VPA | 0.19 | 0.12 | ||||
Drd1a | Control | 1.00 | 0.27 | −7.49 | Down-regulated | |
VPA | 0.13 | 0.06 | ||||
HPC | Htr1b | Control | 1.00 | 0.66 | −11.23 | Down-regulated |
VPA | 0.09 | 0.11 | ||||
Htr1d | Control | 1.00 | 0.47 | −4.29 | Down-regulated | |
VPA | 0.23 | 0.13 | ||||
Htr3a | Control | 1.00 | 0.66 | −11.81 | Down-regulated | |
VPA | 0.09 | 0.11 |